No Data
No Data
DexCom (DXCM), Abbott to Launch First FDA Cleared OTC CGMs
Bernstein Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $150
Bernstein analyst Lee Hambright maintains $DexCom(DXCM.US)$ with a buy rating, and maintains the target price at $150.According to TipRanks data, the analyst has a success rate of 67.6% and a total av
Did Your Heart Skip a Beat? Your Wearable Knows. -- Barrons.com
By Bill Alpert The day is approaching when your wristwatch may send you to the hospital. The first portable electrocardiograph was an 85-pound backpack. Today, a 10-gram patch stuck on your chest ca
DexCom(DXCM.US) Officer Sells US$75,317.11 in Common Stock
$DexCom(DXCM.US)$ Officer Brown Michael Jon sold 659 shares of common stock on Jun 28, 2024 at an average price of $114.29 for a total value of $75,317.11.Source: Announcement What is statement of cha
Why Is DexCom, Inc. (DXCM) One Of The Best Growth Stocks for Billionaire Ray Dalio?
ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com
By Jacob Sonenshine Shares of ResMed, a maker of CPAP and other sleep-apnea airway machines, have dropped because of new GLP-1 developments. It's an overreaction -- and the stock is a buy. Shares ar
No Data
Cui Nyonya Kueh : uncle @soyabean89 ... fyi .![undefined undefined](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
soyabean89 Cui Nyonya Kueh: Nike still got room to drop?!![undefined undefined](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
brutal
Trader’s EdgeOP soyabean89: The bearish momentum on the Weekly chart and the Daily chart does look very strong.. - Isaac
12moon : It is interesting to hear from Trader's Edge,but it is risky to follow blindly. Weekly view is too speculative
Cui Nyonya Kueh : "This report is provided for informational and general circulation purposes only and should not be construed as an offer, solicitation, or recommendation for the purchase or sale of securities, futures, or other investment products. It does not take into consideration any particular needs of any person. This advertisement has not been reviewed by the Monetary Authority of Singapore."![undefined undefined](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)